Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 01, 2016
Source ID
10.1016/j.canlet.2016.01.013

Entities

People

  • George P. Tuszynski
  • Mahesh C. Sharma
  • Marc R. Blackman
  • Meena Sharma

Organizations

  • United States Department of Defense